hex-clinical-trial

Status

GENETIC-AF is currently enrolling patients in U.S., Canada and Europe

200 Patients enrolled as of April 26, 2017

Phase 2B interim efficacy analysis outcome anticipated in August 2017 (Guidance as of June 20, 2017)